SFM
AMED

Systematic Financial Management’s Amedisys AMED Stock Holding History

Systematic Financial Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,640
Closed -$326K – 255
2020
Q2 		$326K Sell
1,640
-845
-34% -$158K 0.02% 291
2020
Q1 		$456K Sell
2,485
-1,295
-34% -$230K 0.03% 187
2019
Q4 		$631K Sell
3,780
-415
-10% -$61.7K 0.02% 295
2019
Q3 		$550K Sell
4,195
-5,375
-56% -$700K 0.02% 326
2019
Q2 		$1.16M Sell
9,570
-5,880
-38% -$698K 0.05% 244
2019
Q1 		$1.9M Buy
15,450
+1,765
+13% +$222K 0.07% 240
2018
Q4 		$1.6M Buy
13,685
+2,245
+20% +$265K 0.05% 260
2018
Q3 		$1.43M Sell
11,440
-11,510
-50% -$1.27M 0.03% 365
2018
Q2 		$1.96M Sell
22,950
-445
-2% -$32.7K 0.05% 276
2018
Q1 		$1.41M Sell
23,395
-6,455
-22% -$368K 0.03% 396
2017
Q4 		$1.57M Buy
29,850
+945
+3% +$49.8K 0.03% 348
2017
Q3 		$1.62M Buy
28,905
+420
+1% +$22.2K 0.03% 361
2017
Q2 		$1.79M Sell
28,485
-7,640
-21% -$445K 0.03% 384
2017
Q1 		$1.85M Sell
36,125
-6,300
-15% -$300K 0.03% 373
2016
Q4 		$1.81M Sell
42,425
-192,085
-82% -$8.17M 0.03% 404
2016
Q3 		$11.1M Sell
234,510
-4,808
-2% -$240K 0.16% 167
2016
Q2 		$12.1M Sell
239,318
-76,120
-24% -$3.84M 0.16% 156
2016
Q1 		$15.2M Sell
315,438
-6,145
-2% -$237K 0.19% 130
2015
Q4 		$12.6M Buy
321,583
+217,008
+208% +$8.68M 0.14% 154
2015
Q3 		$3.97M Buy
+104,575
New +$4.41M 0.04% 304
2015
Q1 		– Sell
-173,755
Closed -$5.1M – 663
2014
Q4 		$5.1M Sell
173,755
-825
-0.5% -$20.4K 0.04% 348
2014
Q3 		$3.52M Buy
174,580
+42,325
+32% +$817K 0.03% 369
2014
Q2 		$2.21M Buy
132,255
+15,170
+13% +$215K 0.02% 394
2014
Q1 		$1.74M Buy
117,085
+1,180
+1% +$18.2K 0.01% 610
2013
Q4 		$1.7M Buy
115,905
+30,480
+36% +$491K 0.01% 577
2013
Q3 		$1.47M Buy
+85,425
New +$1.27M 0.01% 514

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Systematic Financial Management's AMED Position: Q3 2020 in Review

Systematic Financial Management sold out of Amedisys (AMED) in Q3 2020, closing a stake of 1,640 shares — an estimated $326K sold.

Systematic Financial Management first reported a position in AMED in Q3 2013 and held it in 26 quarters. The position peaked at $15.2M in Q1 2016. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Systematic Financial Management reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 1,640 Amedisys shares in Q3 2020, an estimated $326K.
  • Systematic Financial Management first reported a position in Amedisys in Q3 2013 and held it in 26 quarters.
  • Systematic Financial Management's Amedisys position peaked at $15.2M in Q1 2016.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.